OPTImisation and Standardization of CIRCulating Cell-free DNA Ex-traction Protocols in a Diagnostic Setting
NCT06869070 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2025-03-11
Summary
comparison of blood collection tubes and cell-free DNA extraction to evaluate the best possible combination to obtain high quantity and quality cell-free DNA sample for NGS analyses
Conditions
- Healthy
Sponsors & Collaborators
-
University Hospital Tuebingen
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-04-07
- Primary Completion
- 2025-05-31
- Completion
- 2025-08-31
More Related Trials
-
Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP
NCT04025970 ·Status: UNKNOWN
-
NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression
NCT04364828 ·Status: COMPLETED ·Phase: NA
-
Concordance Between ctDNA Assay and FoundationOne
NCT02620527 ·Status: COMPLETED
-
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
NCT02612350 ·Status: COMPLETED
-
Combating the Diagnostic Impasse in Mitochondrial Diseases: a Transcriptomic Approach in Fibroblasts and Blood Cells
NCT06621732 ·Status: RECRUITING ·Phase: NA
-
Urine Methylation Markers in UTUC
NCT06805630 ·Status: RECRUITING ·Phase: NA
-
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
NCT05676450 ·Status: RECRUITING ·Phase: NA
-
Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas
NCT03194347 ·Status: COMPLETED
-
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972 ·Status: ACTIVE_NOT_RECRUITING
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
NCT06929910 ·Status: RECRUITING
-
Optimization of Radiation Protection Through Genomic Analyses
NCT06253338 ·Status: RECRUITING ·Phase: NA
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN
-
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
NCT05029869 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
NCT03071809 ·Status: TERMINATED
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133 ·Status: RECRUITING
-
Cell-free DNA Methylation Markers for Cancer Screening
NCT03096938 ·Status: UNKNOWN ·Phase: NA
-
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
NCT04530890 ·Status: RECRUITING ·Phase: NA
-
CfDNA in Hereditary And High-risk Malignancies 2
NCT06726642 ·Status: RECRUITING
-
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
NCT04566614 ·Status: COMPLETED
-
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
NCT01406782 ·Status: COMPLETED